Public Profile

Chiesi Ltd.

Chiesi Ltd., a subsidiary of the Chiesi Group, is a prominent player in the global pharmaceutical industry, headquartered in Great Britain. Founded in 1935, the company has established itself as a leader in the development of innovative therapies, particularly in the fields of respiratory, neonatology, and rare diseases. With a strong presence across Europe and expanding operations in other regions, Chiesi Ltd. is committed to improving patient outcomes through its unique portfolio of products. The company is renowned for its cutting-edge inhalation therapies and advanced drug delivery systems, which set it apart in a competitive market. Chiesi Ltd. has achieved significant milestones, including recognition for its sustainable practices and commitment to research and development. As a result, it holds a notable position within the pharmaceutical sector, dedicated to enhancing the quality of life for patients worldwide.

DitchCarbon Score

How does Chiesi Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

47

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Chiesi Ltd.'s score of 47 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Chiesi Ltd.'s reported carbon emissions

Chiesi Ltd., headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate initiatives. However, the company is likely to be engaged in industry-standard practices aimed at reducing environmental impact, as many organisations are increasingly focusing on sustainability and climate action. For a comprehensive understanding of Chiesi Ltd.'s climate commitments, further information would be necessary.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Chiesi Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Chiesi Ltd. is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Chiesi Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Schering NV

BE
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Boehringer Ingelheim

DE
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Curia

US
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Almirall

ES
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Bayer Australia Limited

AU
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers